Research graph
References from Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.ejca.2019.07.001
10.1016/j.ejca.2019.07.001 · External reference
10.1200/jco.19.01381
10.1200/jco.19.01381 · External reference
Unresolved reference
External reference
10.1158/2159-8290.cd-21-1141
10.1158/2159-8290.cd-21-1141 · External reference
10.1038/s41591-023-02583-2
10.1038/s41591-023-02583-2 · External reference
Unresolved reference
External reference
10.1245/s10434-024-16642-6
10.1245/s10434-024-16642-6 · External reference
10.1200/jco-24-01681
10.1200/jco-24-01681 · External reference
10.1016/s1470-2045(22)00518-6
10.1016/s1470-2045(22)00518-6 · External reference
10.1001/jama.2026.9032
10.1001/jama.2026.9032 · External reference
10.1200/jco-25-01828
10.1200/jco-25-01828 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/s1470-2045(21)00004-8
10.1016/s1470-2045(21)00004-8 · External reference
10.1056/nejmoa2312695
10.1056/nejmoa2312695 · External reference
10.1016/s0140-6736(22)01658-0
10.1016/s0140-6736(22)01658-0 · External reference
10.1016/s0140-6736(22)02574-0
10.1016/s0140-6736(22)02574-0 · External reference
Unresolved reference
External reference
10.1056/nejmoa2032125
10.1056/nejmoa2032125 · External reference
10.1016/j.esmoop.2022.100385
10.1016/j.esmoop.2022.100385 · External reference
10.1016/j.annonc.2024.10.829
10.1016/j.annonc.2024.10.829 · External reference
10.1038/s41591-023-02786-7
10.1038/s41591-023-02786-7 · External reference
10.1136/jitc-2025-011998
10.1136/jitc-2025-011998 · External reference
10.1016/s0140-6736(25)01850-1
10.1016/s0140-6736(25)01850-1 · External reference
Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid Malignant tumors: a systematic review and network meta-analysis
10.1002/cai2.34 · 2022 · External reference
Efficacy and safety of PD-1/ PD-L1 inhibitors as adjuvants in the treatment of patients with solid cancers: a systematic review and meta-analysis of randomized controlled trials
10.18632/oncotarget.28855 · 2026 · External reference
10.18632/oncotarget.18316
10.18632/oncotarget.18316 · External reference
10.3389/fmed.2023.1192762
10.3389/fmed.2023.1192762 · External reference
10.1016/j.annonc.2023.01.004
10.1016/j.annonc.2023.01.004 · External reference
10.1038/s41591-022-01851-x
10.1038/s41591-022-01851-x · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/j.eururo.2019.10.026
10.1016/j.eururo.2019.10.026 · External reference
Unresolved reference
External reference
Exploratory analysis from NEOAVAX, a neoadjuvant trial of avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy
10.1200/jco.2025.43.16_suppl.4509 · 2025 · External reference
10.1056/nejmoa2415434
10.1056/nejmoa2415434 · External reference
10.1016/s1470-2045(23)00541-7
10.1016/s1470-2045(23)00541-7 · External reference
Unresolved reference
External reference
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
10.1016/s1470-2045(24)00457-1 · 2024 · External reference
The rationale and emerging use of neoadjuvant immune checkpoint blockade for solid Malignancies
10.1245/s10434-018-6379-8 · 2018 · External reference
Immune checkpoint protein inhibition for cancer: preclinical justification for CTLA-4 and PD-1 blockade and new combinations
10.1053/j.seminoncol.2015.02.015 · 2015 · External reference
Trial watch: immune checkpoint blockers for cancer therapy
10.1080/2162402x.2017.1373237 · 2017 · External reference
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
10.1056/nejmoa2200075 · 2022 · External reference
Liquid biopsy in cancer diagnosis and prognosis: a paradigm shift in precision oncology
10.3389/fmolb.2025.1708518 · 2025 · External reference
Cancer in a drop: liquid biopsy insights from ESMO 2025
10.1016/j.jlb.2026.100469 · 2026 · External reference
